Mar 07, 2023 / 05:50PM GMT
Unidentified Analyst -
(technical difficulty) Kim and John, for joining us and making the long trip out. I know it's the 43rd annual -- Bruce, I can't remember when we first got together, but it's been a lot of years. All of a sudden, I was trying to count it up. Why don't we just start off? I know maybe you want to make some opening comments. And then we'll get into Q&A.
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Yes, so happy to -- let me start out with the exciting opening comments. We're going to make forward-looking statements. See our risk factors. If I refer to non-GAAP financials, we always have a reconciliation on our website. I'll also point out if you're watching me in the room, I have a tremor in my right hand, that's not nerves. If my left hand starts shaking, I'm nervous. So you can differentiate on that.
I'm joined by 2 colleagues here in front of you. Kim Sablich has been with the company since June 1, 2020, runs our U.S. commercial business, overseen a number of successful launches already during her tenure.
Jazz Pharmaceuticals PLC at Cowen Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot